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Summary 
Murine bone marrow Lin-, Ly6A/E + cells have been fractionated on the basis of rhodamine123 
retention  into  Rh123 m~d/hi and  Rh123 l~ subpopulations.  These  populations  have  different 
responses to hemopoietic growth factors with respect to in vitro colony formation. Cells from 
either  fraction  were not  stimulated by only granulocyte-colony-stimulating factor  (G-CSF), 
granulocyte/macrophage colony-stimulating factor (GM-CSF), macrophage colony-stimulating 
factor (M-CSF),  interleukins 1 and 6 (IL-1 and -6),  or leukemia inhibitory factor (LIF) alone. 
The Rh123 m~a/hi, but not the Rh1231~ fraction, contained calls that could be stimulated by either 
stem cell factor (SCF) or IL-3 alone.  When combinations of growth factors were added, the 
Rh123 m~d/hi fraction  produced  more  colonies,  and  responded  to  a  wider  range  of  factor 
combinations than the Rh123 l~ population. When tested in vivo, both populations contained 
no detectable day 8 colony-forming unit-spleen (CFU-S), and similar frequencies of day 13 CFU- 
S. When transplanted into lethally irradiated recipients (100 cells/recipient), significant numbers 
of donor ceils (67-73%) were found in the peripheral blood of Rh123 l~ recipients. Both myeloid 
and lymphoid cells were of donor origin. By comparison, the Rh123 reed/hi population produced 
recipients with  1-2%  donor cells in peripheral blood, the majority of which were lymphoid. 
T 
he publication by Spangrude et al.  (1) of a method for 
enriching murine bone marrow cells on the basis of low 
levels of Thy-1 expression (Thy-ll~  absence of expression 
of a panel of antigens defining mature hemopoietic lineages 
(Lin-),  and  expression  of Sca-1  (the  Sca-1  antigen,  also 
known as Ly6A/E), has generated considerable discussion con- 
cerning the degree of purity and identity of pluripotential 
hemopoietic stem cells (PHSC) 1 (1-8). Ceils with the Thy-1  l~ 
Lin-,  Ly6A/E + phenotype were significantly enriched for 
CFU-S(dl2)  (cells capable of forming spleen colonies 12 d 
after transplantation of lethally irradiated recipients), the im- 
plication being that some of the CFU-spleen (S) were in fact 
PHSC and could therefore reconstitute the hemopoietic system 
of lethally irradiated recipients (1). Support for this concept 
was difficult to assess as the results from only one animal 
grafted with Thy-1  l~ Lin-, Ly6A/E + cells, 6 wk previously, 
were shown (1).  The Thy-1  l~  Lin-,  Ly6A/E + population 
has subsequently been tested at limiting cell numbers (down 
to one cell) for long-term repopulating ability, but only 1 
of 40 to 1 of 13 cells generated detectable blood cells in vivo 
for periods of up to 3-7 wk, with very few cells producing 
progeny for much longer (9). Only 1 of 280 mice transplanted 
1 Abbreviations used in this ~per: CFC, colony-forming  cell; CFU-S, CFU- 
spleen; HPP, high proliferative  potential; LIF, leukemia  inhibitory factor; 
PHSC, pluripotential hemopoietic stem cell; SCF, stem cell factor. 
was able to supply sufficient cells, of donor origin, for sec- 
ondary transplantation  (9).  The Thy-11~  Lin-,  Ly6A/E + 
fraction has been further subdivided on the basis of rhoda- 
mine123 retention (10).  When compared with the Rh123 hi 
subset, it was shown that the Rh123  l~ cells had a lower fre- 
quency of CFU-Sd13, a greater ability to reconstitute spleen 
and bone marrow 13 d after transplantation, and that these 
Rh123 I~ subset-derived marrow cells were able to produce 
donor cells in the peripheral blood of secondary recipients 
for periods of at least 8 wk (10).  Finally, when the thymus 
of secondary recipients was examined, donor cells were de- 
tected in both myeloid and lymphoid populations, the con- 
clusion being that Rh123  l~  Thy-11~  Lin-,  Ly6A/E + cells 
were multipotential (10),  albeit the data obtained was from 
examination of only the thymus, a tissue not normally as- 
sayed for mutipotential cells.  When assayed in vitro, with 
limited combinations of growth factors, a similar frequency 
of cells with colony-forming ability was observed with both 
Rh123  subsets (10). 
We have divided Lin-,  Ly6A/E § cells into Rh1231~ and 
Rh123 med/hi  fractions, and show that these have different re- 
sponses to hemopoietic growth factors with respect to in vitro 
colony formation. In addition, a minimum of 1 in 40 cells 
of the Rh123  l~ population was able to engraft lethally irradi- 
ated recipients, producing both myeloid and lymphoid cells 
for at least 19 wk. In contrast, cells of the Rh123 m~/hi frac- 
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Volume 175  June 1992  1443-1447 tion, after engraftment, predominantly repopulated the lym- 
phoid lineages. 
Materials  and Methods 
Animals.  Mice were used at 6-12 wk of age, and were of the 
following strains: C57BL/Ka-Thy-l.1 (Thy-l.1, Ly5.2), C57BL/Ka- 
Thy-l.2(Thy-l.2,  Ly5.2),  and  C57BL/6-Ly-5.1-Pep3b(Thy-1.2, 
LyS.1). They were bred at The Walter and Eliza Hall Institute of 
Medical Research animal facility under specific pathogen-flee con- 
ditions and were maintained on acidified water. 
FACS  ~.  To prepare cells for FACS  |  sorting, C57BL/Ka-Thy- 
1.1 mice (LyS.2 +) (10-12 animals) were killed by cervical disloca- 
tion, and the cells from both femurs and tibiae were flushed out 
using a 2.5-ml syringe with a 21-gauge needle. After washing, the 
bone marrow cells were resuspended in 10 ml balanced  salt solu- 
tion containing 5% BSS.FCS and 0.1/zg/ml rhodamine123 (Eastman 
Kodak Co., Rochester, NY), and incubated at 37~  for 30 min. 
After washing once,  the cells were resuspended in  10 ml flesh 
BSS.FCS, and incubated at 37~  for another 30 min. The cell sus- 
pension was  then diluted further by the  addition  of 10 ml of 
BSS.FCS, and layered on top of Ficoll (Pharmacia Inc., Piscataway, 
NJ), and centrifuged at 1,600 g for 10 min at room temperature. 
Light density viable bone marrow cells were recovered at the inter- 
phase and washed with  10 ml of BSS.FCS. After washing and 
resuspension in 3 ml of BSS.FCS, the cells were incubated on ice 
for 15 min with a mixture of rat mAbs, GK1.5, 53-6.72, 53-7.3.13, 
RA3-6B2, M1/70.15.11.5,  and RB6-8C5, reactive with specific an- 
tigens on mature T, B, and myeloid cells (neutrophils and mono- 
cytes/macrophages). After washing with 10 ml BSS.FCS and cen- 
trifugation through an FCS underlayer, the cells were resuspended 
in 1 ml of BSS.FCS and mixed together with 1 ml of pre-washed 
magnetic Dynalbeads (Dynalbeads  M450; Dynal Inc., Oslo, Nor- 
way), and incubated for 20 min at 4~  with constant mixing. After 
diluting the mixture by adding 5 ml of flesh BSS.FCS, the beads, 
together with the cells bound to them, were removed magneti- 
cally. The procedure was repeated twice to both bead and bead-flee 
cell populations.  The bead-flee cell fractions were pooled, cen- 
trifuged, and were then stained  sequentially for 15 min each in 
0.5 ml vol on ice with PE-conjugated goat anti-rat Ig (mouse ab- 
sorbed), biotinylated E13 161.7 mAb and Texas red-avidin.  Each 
staining step was followed by a washing step with 10 ml of BSS.FCS, 
and the bone marrow cells were pre-incubated with 50/zg normal 
rat Ig for 2-3 min before the addition of biotinylated E13 161.7 
Ab. After the final wash,  the cells were resuspended in 3 ml of 
BSS.FCS containing 10/zg/ml pmpidium iodide (Calbiochem Corp., 
La Jolla, CA), and filtered through a 63-#m pore size nylon screen. 
FACS  |  was performed using an unmodified FACStar-Plus |  instru- 
ment (Becton Dickinson Immunocytometry  Systems, San Jose, CA). 
All cells were kept at 4~  throughout the whole procedure. After 
completion of cell sorting, the deflected cells were centrifuged at 
1,500 rpm for 5 min, resuspended,  and counted using a hemo- 
cytometer. 
In Vitro Cultures.  Marrow Lin-, Ly6A/E  + cells flactionated 
into Rh1231~  or tLh123  m.a/h~ subpopulations as indicated in Fig.  1 
(bottom), were cultured at 100-200 cells/culture in duplicate 35-ram 
petri dishes. The cells were immobilized in 1 ml of agar medium 
and stimulated by various combinations of the following stimuli 
at 1,000 U/ml unless specified otherwise: murine II.-3, GM-CSF, 
M-CSF, or human G-CSF, prepared in this laboratory and kindly 
provided by Dr. N. A. Nicola. Human IL-6 (kindly provided by 
Sandoz, Basel, Switzerland) and rat SCF (kindly provided by Dr. 
Zsebo, Amgen, Thousand Oaks, CA) were used at 0.5/zg/ml and 
200 ng/ml, respectively. Recombinant human ID1 (kindly provided 
by Dr. A. Gearing, Oxford University, Oxford, UK) was used at 
100 U/ml. Colonies of >50 cells were scored at day 12 of incuba- 
tion. The cell types within colonies were determined in situ after 
fixation of cultures  with  2.5%  glutaraldehyde,  air-drying,  and 
staining for acetylcholinesterase  and with hematoxylin and Luxol 
Fast blue. 
Transplantation.  Recipient animals, C57BL/6-Ly-5.1-Pep  ~  (Ly5.1) 
were exposed to 11.0 Gy of 7 radiation from a 137Cs source (Atomic 
Energy, Ottawa, Canada) at a dose rate of 31cGy/min. The 11.0- 
Gy dose was delivered  in two equal exposures,  given 3 h apart. 
Irradiated recipients were transplanted intravenously with indicated 
numbers of Rh123 ~, Lin-, Ly6A/E  +, or Rh123 m~, Lin-, Ly6A/ 
E + cells in the absence of any filler cells. Animals were maintained 
on aqueous antibiotics (neomycin sulphate,  1.1 grams/liter for at 
least 3 wk after transplantation. Hemopoietic reconstitution was 
determined by the percentage of donor-derived  (LyS.2  +) nucleated 
cells in the peripheral blood of recipient (LyS.  1) animals using Ly5.2 
allelic-specific mAb, $450-15.2  (kindly provided by Dr. I. Mack- 
enzie, University of Melbourne, Victoria, Australia), together with 
rat mAbs, RA3-6B2 (for B cells) and Gkl.5 and 53-6.72  (for T 
lymphocytes). Forward and perpendicular light scatter were used 
to define granulocytes and monocytes/macrophages, and this was 
confirmed by using the myelomonocytic-specific  rat mAbs,  RB6- 
8C5 and M1/70. 
Resu|ts 
Isolation of Rhl23 Subsets of Ly6A/E +, Lin-  Cells.  We 
have isolated routine Lin-, Ly6A/E + cells as these have been 
shown  to  be  phenotypically  and  functionally  similar  to 
Thy-1  l~  Lin-,  Ly6A/E +  cells  (11).  Although  the  Lin-, 
Ly6A/E + population contained only 30-50%  Thy-11~ cells 
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Figure 1.  Fractionation  of Lin-,  Ly6A/E § cells  by P~123  retention. 
(~p)  Relative cell number vs.  relative Rh123 fluorescence of Lin-, 
Ly6A/E + marrow cells (solid line) compared with normal bone marrow 
cells (dashed  line). (Bottom)  Relative R.h123 fluorescence  vs. forward light 
scatter of Lin-, Ly6A/E + cells. The two windows show regions from 
which the two Kh123 subpopulations were collected. 
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Figure 2.  Colony  formation in vitro by rhodaminelZ3 
fractions of Lin-, Ly6A/E § bone marrow cells. Results 
represent mean +  SD of quadruplicate cultures scored 
on day 12 of incubation. (A) is data from cultures of 
tLli123  Io. (/3) data from Rh123 'nod/hi cells. 
and a twofold-lower frequency of day 13 CFU-S, their ability 
to confer long-term in vivo hemopoietic engraftment was 
not significantly impaired compared with the homogenous 
Thy-11~ Lin-, Ly-6A/E + cells (11). We have further sub- 
fractionated the Lin-, Ly-6A/E + marrow population using 
the fluorescent dye, rhodamine123. Fig. 1 (top) shows the dis- 
tribution of Ly6A/E +,  Lin-  cells with reference to their 
Rh123 fluorescence intensity. The Ly6A/E + , Lin- popula- 
tion can be divided into two recognizable populations, namely 
Rh123  l~ and Rh123  =~d/hi, based on relative  forward light 
scatter characteristics (Fig. 1, bottom). When compared with 
a standard reference cell population, lymph node cells, which 
had a mean forward light scatter at channel 109, the Rh123  L' 
population had a mean forward light scatter at channel number 
118, and the P,  h123 mea/h~ population had one at 130. Mor- 
phologically, the majority of the Rh1231~ cells were small 
mononuclear cells with a chromatin pattern resembling that 
of small  lymphocytes, whereas  those of the  Rh123  med/hi 
population were medium-sized blasts. 
In Vitro Colony Formation.  To evaluate the in vitro colony- 
forming cell (CFC) content of these populations, cells (150 
cells/culture) from each population were cultured in semi- 
solid agar medium stimulated with recombinant cytokines 
used either alone, or in various combinations. Colony for- 
mation did not occur,  with either fraction, when cultures 
contained only G-,  GM-,  M-CSF,  IL-1, -6,  or  leukemia 
inhibitory factor  (Fig.  2).  The Rh123  m=v~, but  not  the 
Rh1231~  population, contained cells that could be stimulated 
by either SCF or II.-3 alone (Fig. 2). When two cytokines 
were added simultaneously to the cultures, SCF, II.-3, IL-6, 
and G-CSF, markedly synergized with one another and stimu- 
lated colony formation by both populations. However, the 
Rh123  m*d/~ population consistently produced more colonies 
(up to 30 per 150 cells), and was responsive to a wider range 
of cytokine combinations than the Rh123  l~ cells. A similar 
cloning efficiency of 30-50% for both populations was ob- 
served when all seven of the growth factors tested were added 
simultaneously to cultures. Morphological analysis of these 
macroscopic colonies,  stimulated by the addition of seven 
factors,  showed no significant  difference between the two 
Rh123 populations. The majority of colonies consisted of 
neutrophils and macrophages, but some (10-20%) mixed colo- 
nies (containing eosinophils and/or megakaryocytes) were also 
observed.  As most of the colonies were macroscopic in size 
and required multiple cytokines for their optimal growth, 
these can be classified as being derived from high prolifera- 
tive potential CFCs (HPP-CFC) (12). 
In Vivo Repopulation.  To evaluate functional ability in vivo, 
100 cells from each Rh123 population were transplanted into 
lethally  irradiated  congenic  Ly-5.1 recipients.  Both  the 
Rh123  l~ and Rh123  m~m populations contained no detectable 
day 8 CFU-S and had a similar frequency of day 13 CFU-S 
(Table 1). In other experiments, the Kh123  I~ cells produced 
about twofold-less day 13 spleen colonies than the Kh  hi ceils 
(data not shown). Both populations conferred a similar level 
of radioprotection to the lethally irradiated recipients (Table 
1). However,  when the surviving recipients were examined 
at both 8 and 19 wk after transplantation, significant levels 
of donor-derived (LyS.2) peripheral blood nucleated cells were 
found only in  mice receiving Rh123  i~  Lin-,  Ly-6A/E + 
cells, a median (_+  SE)of 67.5  __  5.7%  and 72.7  _+  8.6, 
at 8 and 19 wk respectively, compared with 2.2 _+ 1.7% and 
0.8  +_ 0.6% in mice transplanted with Kh123  m-a/hi, Lin-, 
Ly-6A/E +  cells.  Furthermore,  whereas  donor-derived 
nucleated blood cells were of both lymphoid and myeloid 
lineages in recipients transplanted with 100 Rh123  l~ Lin-, 
Ly-6A/E + cells (Fig. 3), donor-derived circulating myeloid 
Table  1.  CFU-S  Content of Rh123  u and Rh123 "d/~ Fractions 
of Lin-, Ly6A/E § Cells 
No. of spleen 
colonies* 
No.  of cells  Percent survival* 
transplanted  (30 d)  Day 8  Day 13 
100 Kh1231~  90  0  _+  0  4.5  _+  1.7 
100 Kh123  m'a/m  90  0  _+  0  4.5  _+  0.6 
* Ten animals transplanted  in each group, 
t Mean number of spleen colonies  +  SD per 100 transplanted  cells. 
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Figure 3.  Percentage of donor cells in peripheral blood of recipients trans- 
planted 17-19  wk previously. 
cells were absent in recipients transplanted with R.h123  m~/hi, 
Lin-,  Ly6A/E +  cells  (Fig.  3).  Even  in  recipients  trans- 
planted with 1,500 ILh123  m'a/hs cells, although displaying an 
increased level (a median of 12.0  _+  1.9% measured 17 wk 
posttransplantation)  of donor-derived nucleated peripheral 
blood cells, the majority of these were lymphoid (B and T) 
cells (Fig. 3). Only one of four recipients examined, showed 
the presence of about 8% donor cells in the circulating my- 
eloid population  (Fig.  3). 
Discussion 
The Thy-1  ]~  Lin-,  LY6A/E + cell population has been 
fractionated on the basis of rhodamine123 retention (10). It 
was concluded, albeit on a limited number of assays, that 
there was no difference between the Rh123 l~ and Rh123 hi 
subsets with regard to in vitro CFC numbers (10). A similar 
result has also been reported recently, although once again 
using only a limited number of growth factor combinations 
(13). However, it was also shown that the ILh123  ~~ popula- 
tion was capable of a 13-d marrow repopulation, and that 
these marrow cells contained sufficient donor cell reserves 
to repopulate secondary lethally irradiated recipients for up 
to 8 wk, although multilineage development was only tested 
for and demonstrated in the thymus (10). These results sug- 
gested that the Rah123  I~ population was less mature than the 
Rh123 hi fraction, but because the cells  had been passaged 
through primary recipients for 13 d before secondary trans- 
plantation,  it  was  not  possible  to  determine  the  direct 
repopulating ability of the Rh123 l~ cells,  or the frequency 
of such cells.  Although the experiments were incomplete, 
it was suggested that the differences observed in vivo may 
have been due to localization in differing microenvironments, 
rather than to inherent differences between the Rh123 sub- 
sets  (8). 
The results presented here, demonstrate that the two Rh123 
fractions are functionally different. The in vitro results dem- 
onstrate that in the same environment, there is a differential 
responsiveness to  individual and combinations  of growth 
factors.  The in vivo results also demonstrate that there are 
functional differences between the two Rh123  subpopula- 
tions.  The Rh123 l~ population  repopulated both  myeloid 
and lymphoid lineages, whereas the Rh123 m~/hi population 
predominantly engrafted the lymphoid lineages. Taken to- 
gether, these in vitro and in vivo results suggest that there 
is  genuine intrinsic heterogeneity within  the cells  of the 
Lin-, Ly6A/E + phenotype that accounts for the differing 
behavior in vitro and after engraftment in vivo. 
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